Publication:
SURROGATE MARKERS OF CARDIOVASCULAR DISEASE IN NONDIABETIC CHRONIC KIDNEY DISEASE: MEAN PLATELET VOLUME AND B-THROMBOGLOBULIN

dc.contributor.authorDEMIRTUNC, Refik
dc.contributor.authorULUKOYLU-MENGUC, Meral
dc.contributor.authorKAYATAS, Kadir
dc.contributor.authorOZKAN, Sevil
dc.contributor.institutionauthorKARATOPRAK, CUMALİ
dc.date.accessioned2019-10-05T14:52:03Z
dc.date.available2019-10-05T14:52:03Z
dc.date.issued2014-01-01
dc.description.abstractAims: To investigate the levels of mean platelet volume (MPV) and beta-thromboglobulin (beta-TG), two of platelet activation markers, in non-diabetic patients in different stages of chronic kidney disease (CKD), who were receiving or not receiving hemodialysis.
dc.identifier10.1002/tox.20430
dc.identifier.citationDEMIRTUNC R., ULUKOYLU-MENGUC M., Karatoprak C., KAYATAS K., OZKAN S., -SURROGATE MARKERS OF CARDIOVASCULAR DISEASE IN NONDIABETIC CHRONIC KIDNEY DISEASE: MEAN PLATELET VOLUME AND B-THROMBOGLOBULIN-, ACTA MEDICA MEDITERRANEA, cilt.30, ss.929-933, 2014
dc.identifier.scopus84903434923
dc.identifier.urihttps://hdl.handle.net/20.500.12645/4910
dc.identifier.wosWOS:000344634300031
dc.language.isoen
dc.titleSURROGATE MARKERS OF CARDIOVASCULAR DISEASE IN NONDIABETIC CHRONIC KIDNEY DISEASE: MEAN PLATELET VOLUME AND B-THROMBOGLOBULIN
dc.typeArticle
dspace.entity.typePublication
local.article.journalnameEnvironmental toxicology
local.avesis.id78a7e543-6cd2-4d40-8760-c1e5b7bc5c09
local.avesis.response4780
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublicationb04cfc56-9dea-4145-a140-c66dc7ace166
relation.isAuthorOfPublication.latestForDiscoveryb04cfc56-9dea-4145-a140-c66dc7ace166
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c
Files